{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000855","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.088236+00:00","generated_at":"2026-05-24T03:41:55.235296+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"confidence":"high","headline":"Oragenics Q1 update: $5M raised, ONP-002 Phase IIa trial advances","bullets":["Raised ~$2.6M via ATM equity and ~$2.25M via non-dilutive debt; submitted DoD grant for concussion program.","Submitted Investigator's Brochure for Phase IIa trial in Australia; trial listed on ClinicalTrials.gov; awaiting HREC approval.","Partnered with BRAINBox Solutions to combine intranasal ONP-002 with diagnostic biomarkers for personalized concussion care.","Upcoming milestones: HREC approval and first patient enrollment in Q2 2025; Phase IIa enrollment completion by Q4 2025.","Simplified capital structure by converting all preferred shares to common; annual meeting set for May 2, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000855","json":"https://secwatch.observer/filing/0001641172-25-000855.json","markdown":"https://secwatch.observer/filing/0001641172-25-000855.md","text":"https://secwatch.observer/filing/0001641172-25-000855.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000164117225000855/0001641172-25-000855-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000164117225000855/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:41:55.235296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}